These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31605228)

  • 1. Clinical Applications of Circulating Tumor Cells in Breast Cancer.
    Cobain EF; Paoletti C; Smerage JB; Hayes DF
    Recent Results Cancer Res; 2020; 215():147-160. PubMed ID: 31605228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of CTC Clusters in Breast Cancer Metastasis.
    Piñeiro R; Martínez-Pena I; López-López R
    Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells in breast cancer.
    Bidard FC; Proudhon C; Pierga JY
    Mol Oncol; 2016 Mar; 10(3):418-30. PubMed ID: 26809472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markers of circulating breast cancer cells.
    López-Muñoz E; Méndez-Montes M
    Adv Clin Chem; 2013; 61():175-224. PubMed ID: 24015603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction - Biology of Breast Cancer Metastasis and Importance of the Analysis of CTCs.
    Piñeiro R
    Adv Exp Med Biol; 2020; 1220():1-10. PubMed ID: 32304076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells and serum levels of MMP-2, MMP-9 and VEGF as markers of the metastatic process in patients with high risk of metastatic progression.
    Skerenova M; Mikulova V; Capoun O; Zima T; Tesarova P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2017 Sep; 161(3):272-280. PubMed ID: 28529342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack.
    Bulfoni M; Turetta M; Del Ben F; Di Loreto C; Beltrami AP; Cesselli D
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy in Metastasized Breast Cancer as Basis for Treatment Decisions.
    Krawczyk N; Fehm T; Banys-Paluchowski M; Janni W; Schramm A
    Oncol Res Treat; 2016; 39(3):112-6. PubMed ID: 27031542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor cell-platelet interaction in breast cancer metastasis.
    Felding-Habermann B
    Pathophysiol Haemost Thromb; 2003; 33 Suppl 1():56-8. PubMed ID: 12955006
    [No Abstract]   [Full Text] [Related]  

  • 10. Circulating tumor cell clusters: What we know and what we expect (Review).
    Hong Y; Fang F; Zhang Q
    Int J Oncol; 2016 Dec; 49(6):2206-2216. PubMed ID: 27779656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current challenges in metastasis: disseminated and circulating tumor cells detection.
    Shahneh FZ
    Hum Antibodies; 2013; 22(3-4):77-85. PubMed ID: 24961866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for circulating tumor cells in the management of breast cancer?
    Hayes DF; Smerage J
    Clin Cancer Res; 2008 Jun; 14(12):3646-50. PubMed ID: 18559576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cancer cells in peripheral lymph and blood and their effect on the morbidity of patients with breast cancer].
    Putyrskiĭ LA
    Ross Med Zh; 1992; (4):39-42. PubMed ID: 1521020
    [No Abstract]   [Full Text] [Related]  

  • 14. New insights into the mechanisms of organ-specific breast cancer metastasis.
    Lorusso G; Rüegg C
    Semin Cancer Biol; 2012 Jun; 22(3):226-33. PubMed ID: 22504658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of cancer before distant metastasis.
    Coumans FA; Siesling S; Terstappen LW
    BMC Cancer; 2013 Jun; 13():283. PubMed ID: 23763955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the metastatic seeds of breast cancer.
    Kuo AH; Clarke MF
    Nat Biotechnol; 2013 Jun; 31(6):504-5. PubMed ID: 23752434
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of circulating tumor cells in breast cancer patients: prognostic predictive role.
    Turker I; Uyeturk U; Sonmez OU; Oksuzoglu B; Helvaci K; Arslan UY; Budakoglu B; Alkis N; Aksoy S; Zengin N
    Asian Pac J Cancer Prev; 2013; 14(3):1601-7. PubMed ID: 23679243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumor cells as a prognostic marker for efficacy in the randomized phase III JO21095 trial in Japanese patients with HER2-negative metastatic breast cancer.
    Iwata H; Masuda N; Yamamoto D; Sagara Y; Sato N; Yamamoto Y; Saito M; Fujita T; Oura S; Watanabe J; Tsukabe M; Horiguchi K; Hattori S; Matsuura Y; Kuroi K
    Breast Cancer Res Treat; 2017 Apr; 162(3):501-510. PubMed ID: 28181129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor Cells.
    Paoletti C; Hayes DF
    Adv Exp Med Biol; 2016; 882():235-58. PubMed ID: 26987538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
    Riethdorf S; Pantel K
    Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.